Literature DB >> 6863724

Acinetobacter mediastinitis and pneumonia in a thorotrastoma patient. The oropharyngeal flora as source of infection.

C P Stoutenbeek, H K van Saene, D R Miranda, D van der Waaij.   

Abstract

A case of bilateral pneumonia, mediastinitis and septicaemia caused by Acinetobacter calcoaceticus and Candida albicans is described. The infections occurred after a palliative operation for an esophagotracheal fistula in a thorotrastoma patient. The oropharynx was colonized by the two microorganisms at admission and is presented as the source of these infections. Clinical management and antimicrobial policy, including oropharyngeal decontamination, leading to a good outcome are reported.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863724     DOI: 10.1007/bf01772582

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  4 in total

1.  MALIGNANCY AND OTHER LATE EFFECTS FOLLOWING ADMINISTRATION OF THOROTRAST.

Authors:  J S DA HORTA; L C DA MOTTA; J D ABBATT; M L RORIZ
Journal:  Lancet       Date:  1965-07-31       Impact factor: 79.321

2.  Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control.

Authors:  M Castle; J H Tenney; M P Weinstein; T C Eickhoff
Journal:  Heart Lung       Date:  1978 Jul-Aug       Impact factor: 2.210

3.  The treatment of oesophageal perforations.

Authors:  L Bergdahl; A Henze
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1978

4.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

  4 in total
  1 in total

1.  Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital.

Authors:  W H Crombach; L Dijkshoorn; M van Noort-Klaassen; J Niessen; G van Knippenberg-Gordebeke
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.